Midgard Science

Labs / CDMO: development & manufacturing

OmniParticles

Seoul, South Korea · omniparticles.com

GMP

On your own

Free. Their own form.

Contact OmniParticles directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

OmniParticles is a nanomedicine CDMO that develops nanoparticle drug substances and provides aseptic fill-finish for clinical-phase drug products. It operates in Seoul, Korea, with separate drug substance and drug product GMP facilities in the same building.

They take quote requests by email.

What they offer

  • Nanoparticle drug substance CDMO

    End-to-end development and manufacturing for nanoparticle drug substances, from concept translation and formulation refinement through scale-up and GMP mass production with CMC support.

  • Aseptic sterile fill-finish

    Aseptic fill-finish for preclinical and Phase I/II/III clinical supply, including batches of 2,000–5,000 vials under Grade A conditions in open RABS with a fully single-use product-contact train.

  • GMP and non-GMP drug substance manufacturing

    Manufacturing of nanomedicine drug substance from preparation to purified bulk with GMP-compliant processes.

  • QC/QA analysis

    QC/QA protocols for verifying nanomedicine integrity, safety, and performance against global regulatory standards.

  • Batch records and release documentation

    Preparation of manufacturing reports, CoT, and CoA with full traceability to support regulatory filings.

  • CMC documentation and Module 3 CTD support

    Preparation of essential CMC documentation and Module 3 scientific and technical writing for global regulatory submissions.

  • Regulatory consulting

    Guidance on early-development regulatory strategy and global frameworks for IND and related clinical trial applications.

What they work on

Modalities
Small molecule, Antibody, Peptide, LNP / formulation
Assays and studies
DLS, TEM, zeta-potential, HPLC, SEC, ICP-MS, sterility testing
Instruments and platforms
DLS, TEM, zeta-potential, HPLC, SEC mode, triple detector, ICP-MS
Scale and capacity
batches of 2,000–5,000 vials, GMP drug substance manufacturing plant, purpose-built sterile drug product suite, two manufacturing suites
Therapeutic areas
acute diseases, chronic diseases, inflammatory diseases, ischemic stroke, intracerebral hemorrhage, sepsis, subarachnoid hemorrhage, traumatic brain injury
Type
CRDMO
Sites
Seoul, Korea
Quality
current EU GMP Annex 1 (sterile fill-finish suite and operations) · GMP (drug substance manufacturing and facility operations) · FDA IND approved (cerium oxide nanomedicine case highlight)
Serves
global
Address
Engineering 2021, 7 (9), 4446–4453 •Biomaterials 2020, 239, 119859 •ACS Nano
Founded
2011

Similar labs. Esco Aster, CordenPharma, Adragos Pharma, ARSI Canada Inc

Found in a contract services directory. Listing built from omniparticles.com. Work here? Claim this listing.

OmniParticles · Midgard Science